Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Farnesoid X receptor in human malignancies: an overview.

4° JOINT MEETING OF PATHOLOGY AND LABORATORY MEDICINE SIPMET–SIPMEL - SECOND JOINT MEETING IN COLLABORATION WITH ASIP–AMP–UEMS–WASPALM - 4° SIPMEL NATIONAL CONGRESS - 34° SIPMET NATIONAL CONGRESS - 4° CONGRESS OF PATHOLOGY AND LABORATORY MEDICINE, Giordano C, Barone I, Bonofiglio D, Catalano S, Andò S.

J Biol Regul Homeost Agents. 2018 Jul-Aug;32(4 Suppl. 1):1-7. No abstract available.

PMID:
30761858
2.

Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms.

Andò S, Gelsomino L, Panza S, Giordano C, Bonofiglio D, Barone I, Catalano S.

Cancers (Basel). 2019 Jan 9;11(1). pii: E62. doi: 10.3390/cancers11010062. Review.

3.

Leptin Receptor as a Potential Target to Inhibit Human Testicular Seminoma Growth.

Panza S, Gelsomino L, Malivindi R, Rago V, Barone I, Giordano C, Giordano F, Leggio A, Comandè A, Liguori A, Aquila S, Bonofiglio D, Andò S, Catalano S.

Am J Pathol. 2019 Mar;189(3):687-698. doi: 10.1016/j.ajpath.2018.11.012. Epub 2019 Jan 2.

PMID:
30610844
4.

Activation of Farnesoid X Receptor impairs the tumor-promoting function of breast cancer-associated fibroblasts.

Barone I, Vircillo V, Giordano C, Gelsomino L, Győrffy B, Tarallo R, Rinaldi A, Bruno G, Caruso A, Romeo F, Bonofiglio D, Andò S, Catalano S.

Cancer Lett. 2018 Nov 28;437:89-99. doi: 10.1016/j.canlet.2018.08.026. Epub 2018 Sep 1.

PMID:
30176263
5.

Phosphodiesterase type 5 and cancers: progress and challenges.

Barone I, Giordano C, Bonofiglio D, Andò S, Catalano S.

Oncotarget. 2017 Oct 12;8(58):99179-99202. doi: 10.18632/oncotarget.21837. eCollection 2017 Nov 17. Review.

6.

Erratum to: Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells.

Bonofiglio D, Gabriele S, Aquila S, Qi H, Belmonte M, Catalano S, Andò S.

Breast Cancer Res Treat. 2017 Nov;166(1):325-326. doi: 10.1007/s10549-017-4456-5. No abstract available.

PMID:
28822120
7.

Benzofuran-2-acetic ester derivatives induce apoptosis in breast cancer cells by upregulating p21Cip/WAF1 gene expression in p53-independent manner.

Giordano C, Rovito D, Barone I, Mancuso R, Bonofiglio D, Giordano F, Catalano S, Gabriele B, Andò S.

DNA Repair (Amst). 2017 Mar;51:20-30. doi: 10.1016/j.dnarep.2017.01.006. Epub 2017 Jan 15.

PMID:
28108275
8.

Monitoring the effects of iodine prophylaxis in the adult population of southern Italy with deficient and sufficient iodine intake levels: a cross-sectional, epidemiological study.

Bonofiglio D, Catalano S, Perri A, Santoro M, Siciliano L, Lofaro D, Gallo M, Marsico S, Bruno R, Giordano C, Barone I, Andò S.

Br J Nutr. 2017 Jan;117(1):170-175. doi: 10.1017/S0007114516004499. Epub 2017 Jan 18.

9.

Leptin, obesity and breast cancer: progress to understanding the molecular connections.

Barone I, Giordano C, Bonofiglio D, Andò S, Catalano S.

Curr Opin Pharmacol. 2016 Dec;31:83-89. doi: 10.1016/j.coph.2016.10.003. Epub 2016 Nov 2. Review.

PMID:
27816025
10.

Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression.

Rovito D, Gionfriddo G, Barone I, Giordano C, Grande F, De Amicis F, Lanzino M, Catalano S, Andò S, Bonofiglio D.

Oncotarget. 2016 Oct 4;7(40):65109-65124. doi: 10.18632/oncotarget.11371.

11.

Ligand activated progesterone receptor B drives autophagy-senescence transition through a Beclin-1/Bcl-2 dependent mechanism in human breast cancer cells.

De Amicis F, Guido C, Santoro M, Giordano F, Donà A, Rizza P, Pellegrino M, Perrotta I, Bonofiglio D, Sisci D, Panno ML, Tramontano D, Aquila S, Andò S.

Oncotarget. 2016 Sep 6;7(36):57955-57969. doi: 10.18632/oncotarget.10799.

12.

Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth.

Panza S, Malivindi R, Chemi F, Rago V, Giordano C, Barone I, Bonofiglio D, Gelsomino L, Giordano F, Andò S, Catalano S.

Am J Pathol. 2016 May;186(5):1328-39. doi: 10.1016/j.ajpath.2015.12.024. Epub 2016 Mar 8.

PMID:
26968343
13.

Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy.

Giordano C, Barone I, Vircillo V, Panza S, Malivindi R, Gelsomino L, Pellegrino M, Rago V, Mauro L, Lanzino M, Panno ML, Bonofiglio D, Catalano S, Andò S.

Sci Rep. 2016 Feb 22;6:21782. doi: 10.1038/srep21782.

14.

Identification of novel 2-(1H-indol-1-yl)-benzohydrazides CXCR4 ligands impairing breast cancer growth and motility.

Grande F, Barone I, Aiello F, Brancale A, Cancellieri M, Badolato M, Chemi F, Giordano C, Vircillo V, Bonofiglio D, Garofalo A, Andò S, Catalano S.

Future Med Chem. 2016;8(2):93-106. doi: 10.4155/fmc.15.176. Epub 2016 Jan 25.

PMID:
26807787
15.

Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy.

Catalano S, Campana A, Giordano C, Győrffy B, Tarallo R, Rinaldi A, Bruno G, Ferraro A, Romeo F, Lanzino M, Naro F, Bonofiglio D, Andò S, Barone I.

Clin Cancer Res. 2016 May 1;22(9):2271-82. doi: 10.1158/1078-0432.CCR-15-1900. Epub 2015 Dec 14.

16.

Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.

Giordano C, Chemi F, Panza S, Barone I, Bonofiglio D, Lanzino M, Cordella A, Campana A, Hashim A, Rizza P, Leggio A, Győrffy B, Simões BM, Clarke RB, Weisz A, Catalano S, Andò S.

Oncotarget. 2016 Jan 12;7(2):1262-75. doi: 10.18632/oncotarget.6014.

17.

Omega-3 DHA- and EPA-dopamine conjugates induce PPARγ-dependent breast cancer cell death through autophagy and apoptosis.

Rovito D, Giordano C, Plastina P, Barone I, De Amicis F, Mauro L, Rizza P, Lanzino M, Catalano S, Bonofiglio D, Andò S.

Biochim Biophys Acta. 2015 Nov;1850(11):2185-95. doi: 10.1016/j.bbagen.2015.08.004. Epub 2015 Aug 11.

PMID:
26272430
18.

Natural Products as Promising Antitumoral Agents in Breast Cancer: Mechanisms of Action and Molecular Targets.

Bonofiglio D, Giordano C, De Amicis F, Lanzino M, Andò S.

Mini Rev Med Chem. 2016;16(8):596-604. Review.

PMID:
26156544
19.

A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo.

Catalano S, Leggio A, Barone I, De Marco R, Gelsomino L, Campana A, Malivindi R, Panza S, Giordano C, Liguori A, Bonofiglio D, Liguori A, Andò S.

J Cell Mol Med. 2015 May;19(5):1122-32. doi: 10.1111/jcmm.12517. Epub 2015 Feb 27.

20.

Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells.

Mauro L, Pellegrino M, Giordano F, Ricchio E, Rizza P, De Amicis F, Catalano S, Bonofiglio D, Panno ML, Andò S.

FASEB J. 2015 May;29(5):2150-60. doi: 10.1096/fj.14-262808. Epub 2015 Feb 5.

PMID:
25657113
21.

Androgens inhibit aromatase expression through DAX-1: insights into the molecular link between hormone balance and Leydig cancer development.

Maris P, Campana A, Barone I, Giordano C, Morelli C, Malivindi R, Sisci D, Aquila S, Rago V, Bonofiglio D, Catalano S, Lanzino M, Andò S.

Endocrinology. 2015 Apr;156(4):1251-62. doi: 10.1210/en.2014-1654. Epub 2015 Jan 20.

PMID:
25603045
22.

The Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and Progression.

Andò S, Barone I, Giordano C, Bonofiglio D, Catalano S.

Front Oncol. 2014 Nov 26;4:340. doi: 10.3389/fonc.2014.00340. eCollection 2014. Review.

23.

Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.

Catalano S, Giordano C, Panza S, Chemi F, Bonofiglio D, Lanzino M, Rizza P, Romeo F, Fuqua SA, Maggiolini M, Andò S, Barone I.

Breast Cancer Res Treat. 2014 Jul;146(2):273-85. doi: 10.1007/s10549-014-3017-4. Epub 2014 Jun 14.

PMID:
24928526
24.

Evidences that estrogen receptor α interferes with adiponectin effects on breast cancer cell growth.

Mauro L, Pellegrino M, De Amicis F, Ricchio E, Giordano F, Rizza P, Catalano S, Bonofiglio D, Sisci D, Panno ML, Andò S.

Cell Cycle. 2014;13(4):553-64. doi: 10.4161/cc.27455. Epub 2013 Dec 12.

PMID:
24335340
25.

T3 enhances thyroid cancer cell proliferation through TRβ1/Oct-1-mediated cyclin D1 activation.

Perri A, Catalano S, Bonofiglio D, Vizza D, Rovito D, Qi H, Aquila S, Panza S, Rizza P, Lanzino M, Andò S.

Mol Cell Endocrinol. 2014 Jan 25;382(1):205-217. doi: 10.1016/j.mce.2013.10.001. Epub 2013 Oct 9.

PMID:
24121026
26.

DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation.

Lanzino M, Maris P, Sirianni R, Barone I, Casaburi I, Chimento A, Giordano C, Morelli C, Sisci D, Rizza P, Bonofiglio D, Catalano S, Andò S.

Cell Death Dis. 2013 Jul 11;4:e724. doi: 10.1038/cddis.2013.235.

27.

Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.

De Amicis F, Perri A, Vizza D, Russo A, Panno ML, Bonofiglio D, Giordano C, Mauro L, Aquila S, Tramontano D, Andò S.

J Cell Physiol. 2013 Oct;228(10):2054-62. doi: 10.1002/jcp.24372.

PMID:
23553645
28.

Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes.

Bonofiglio D, Santoro A, Martello E, Vizza D, Rovito D, Cappello AR, Barone I, Giordano C, Panza S, Catalano S, Iacobazzi V, Dolce V, Andò S.

Biochim Biophys Acta. 2013 Jun;1831(6):1027-36. doi: 10.1016/j.bbalip.2013.01.014. Epub 2013 Jan 28.

PMID:
23370576
29.

In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells.

De Amicis F, Russo A, Avena P, Santoro M, Vivacqua A, Bonofiglio D, Mauro L, Aquila S, Tramontano D, Fuqua SA, Andò S.

Mol Nutr Food Res. 2013 May;57(5):840-53. doi: 10.1002/mnfr.201200560. Epub 2013 Jan 16.

30.

Red wine consumption may affect sperm biology: the effects of different concentrations of the phytoestrogen myricetin on human male gamete function.

Aquila S, Santoro M, De Amicis F, Guido C, Bonofiglio D, Lanzino M, Cesario MG, Perrotta I, Sisci D, Morelli C.

Mol Reprod Dev. 2013 Feb;80(2):155-65. doi: 10.1002/mrd.22145. Epub 2013 Jan 30.

PMID:
23280600
31.

Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells.

Giordano C, Vizza D, Panza S, Barone I, Bonofiglio D, Lanzino M, Sisci D, De Amicis F, Fuqua SA, Catalano S, Andò S.

Mol Oncol. 2013 Jun;7(3):379-91. doi: 10.1016/j.molonc.2012.11.002. Epub 2012 Nov 23.

32.

Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells.

Rovito D, Giordano C, Vizza D, Plastina P, Barone I, Casaburi I, Lanzino M, De Amicis F, Sisci D, Mauro L, Aquila S, Catalano S, Bonofiglio D, Andò S.

J Cell Physiol. 2013 Jun;228(6):1314-22. doi: 10.1002/jcp.24288.

PMID:
23168911
33.

Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.

Catalano S, Panza S, Malivindi R, Giordano C, Barone I, Bossi G, Lanzino M, Sirianni R, Mauro L, Sisci D, Bonofiglio D, Andò S.

Int J Cancer. 2013 May 15;132(10):2237-47. doi: 10.1002/ijc.27915. Epub 2012 Nov 7.

34.

Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells.

Barone I, Giordano C, Malivindi R, Lanzino M, Rizza P, Casaburi I, Bonofiglio D, Catalano S, Andò S.

Endocrinology. 2012 Nov;153(11):5157-66. doi: 10.1210/en.2012-1561. Epub 2012 Sep 7.

PMID:
22962253
35.

Identification of bioactive constituents of Ziziphus jujube fruit extracts exerting antiproliferative and apoptotic effects in human breast cancer cells.

Plastina P, Bonofiglio D, Vizza D, Fazio A, Rovito D, Giordano C, Barone I, Catalano S, Gabriele B.

J Ethnopharmacol. 2012 Mar 27;140(2):325-32. doi: 10.1016/j.jep.2012.01.022. Epub 2012 Jan 24.

PMID:
22301448
36.

Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells.

Barone I, Catalano S, Gelsomino L, Marsico S, Giordano C, Panza S, Bonofiglio D, Bossi G, Covington KR, Fuqua SA, Andò S.

Cancer Res. 2012 Mar 15;72(6):1416-27. doi: 10.1158/0008-5472.CAN-11-2558. Epub 2012 Jan 26.

37.

Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation.

Gu G, Barone I, Gelsomino L, Giordano C, Bonofiglio D, Statti G, Menichini F, Catalano S, Andò S.

J Cell Physiol. 2012 Oct;227(10):3363-72. doi: 10.1002/jcp.24035.

PMID:
22213398
38.

In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer.

Catalano S, Mauro L, Bonofiglio D, Pellegrino M, Qi H, Rizza P, Vizza D, Bossi G, Andò S.

Am J Pathol. 2011 Aug;179(2):1030-40. doi: 10.1016/j.ajpath.2011.04.026. Epub 2011 Jun 23.

39.

Bid as a potential target of apoptotic effects exerted by low doses of PPARγ and RXR ligands in breast cancer cells.

Bonofiglio D, Cione E, Vizza D, Perri M, Pingitore A, Qi H, Catalano S, Rovito D, Genchi G, Andò S.

Cell Cycle. 2011 Jul 15;10(14):2344-54. Epub 2011 Jul 15.

PMID:
21654191
40.

Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression.

Giordano C, Catalano S, Panza S, Vizza D, Barone I, Bonofiglio D, Gelsomino L, Rizza P, Fuqua SA, Andò S.

Oncogene. 2011 Sep 29;30(39):4129-40. doi: 10.1038/onc.2011.124. Epub 2011 Apr 18.

41.

Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.

Catalano S, Malivindi R, Giordano C, Gu G, Panza S, Bonofiglio D, Lanzino M, Sisci D, Panno ML, Andò S.

J Biol Chem. 2010 Feb 19;285(8):5581-93. doi: 10.1074/jbc.M109.052670. Epub 2009 Dec 21.

42.

Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells.

Bonofiglio D, Cione E, Qi H, Pingitore A, Perri M, Catalano S, Vizza D, Panno ML, Genchi G, Fuqua SA, Andò S.

Am J Pathol. 2009 Sep;175(3):1270-80. doi: 10.2353/ajpath.2009.081078. Epub 2009 Jul 30.

43.

Rapid estradiol/ERalpha signaling enhances aromatase enzymatic activity in breast cancer cells.

Catalano S, Barone I, Giordano C, Rizza P, Qi H, Gu G, Malivindi R, Bonofiglio D, Andò S.

Mol Endocrinol. 2009 Oct;23(10):1634-45. doi: 10.1210/me.2009-0039. Epub 2009 Jun 25.

44.

Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.

Catalano S, Giordano C, Rizza P, Gu G, Barone I, Bonofiglio D, Giordano F, Malivindi R, Gaccione D, Lanzino M, De Amicis F, Andò S.

J Cell Physiol. 2009 Mar;218(3):490-500. doi: 10.1002/jcp.21622.

PMID:
18988190
45.

Beneficial effects of iodized salt prophylaxis on thyroid volume in an iodine deficient area of southern Italy.

Bonofiglio D, Catalano S, Perri A, Baldini MP, Marsico S, Tagarelli A, Conforti D, Guido R, Andò S.

Clin Endocrinol (Oxf). 2009 Jul;71(1):124-9. doi: 10.1111/j.1365-2265.2008.03432.x. Epub 2008 Sep 24.

PMID:
18844679
46.

Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.

Bonofiglio D, Qi H, Gabriele S, Catalano S, Aquila S, Belmonte M, Andò S.

Endocr Relat Cancer. 2008 Jun;15(2):545-57. doi: 10.1677/ERC-07-0272.

PMID:
18509005
47.

Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells.

Bonofiglio D, Gabriele S, Aquila S, Qi H, Belmonte M, Catalano S, Andò S.

Breast Cancer Res Treat. 2009 Feb;113(3):423-34. doi: 10.1007/s10549-008-9944-1. Epub 2008 Feb 22. Erratum in: Breast Cancer Res Treat. 2017 Nov;166(1):325-326.

PMID:
18293083
48.

Peroxisome proliferator-activated receptor (PPAR)gamma is expressed by human spermatozoa: its potential role on the sperm physiology.

Aquila S, Bonofiglio D, Gentile M, Middea E, Gabriele S, Belmonte M, Catalano S, Pellegrino M, Andò S.

J Cell Physiol. 2006 Dec;209(3):977-86.

PMID:
16972250
49.

Peroxisome proliferator-activated receptor-gamma activates p53 gene promoter binding to the nuclear factor-kappaB sequence in human MCF7 breast cancer cells.

Bonofiglio D, Aquila S, Catalano S, Gabriele S, Belmonte M, Middea E, Qi H, Morelli C, Gentile M, Maggiolini M, Andò S.

Mol Endocrinol. 2006 Dec;20(12):3083-92. Epub 2006 Aug 3.

PMID:
16887883
50.

17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30.

Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A, Musti AM, Picard D, Andò S, Maggiolini M.

Mol Pharmacol. 2006 Oct;70(4):1414-23. Epub 2006 Jul 11.

PMID:
16835357

Supplemental Content

Loading ...
Support Center